With a non-compete covering the Canadian cannabis sector, Bloomberg suggests Linton will be heading join theto the U.S.:
- “Anybody who’s dumb enough to launch a new cannabis company in Canada, I don’t know what they’re doing, they should have been at it six years ago. Canada is done,” he said.
At New Cannabis Ventures, Alan Brochstein reviews the post-Linton "Canopy Growth Ecosystem."
An analyst at Canaccord Genuity predicted $22B in legal U.S. cannabis sales by 2022.
- Bobby Burleson anticipates 2019 domestic sales of $12.8B and a growth rate of 20% annually.
- REC legalization in Illinois was key to him increasing his forecast.
Facebook agreed to run ads for topical CBD products only, Digiday reports. The ban has infuriated brands trying to gain access to the platform.
Members of Congress are stepping up pressure on the FDA to regulate hemp-derived CBD, though it may still take years.
- Brookings Institution scholar John Hudak says “There’s no doubt that the FDA is going to be fairly strict in the way it regulates these products." That probably means crackdowns in store for dodgier manufacturers.
- Canna Law Blog explains the FDA's problem with hemp-derived CBD, which is now legal.
Senate Majority Leader Mitch McConnell (R-Ky.) brought U.S. Agriculture Secretary Sonny Perdue on a tour of a Kentucky hemp farm.
- Israeli vets want to prescribe MED for dogs stressed out by missile attacks. [Not noted in the story: THC is widely considered dangerous for dogs.]
Writing in AdWeek, investor Matthew Nordgren describes how influencers and forms of guerilla marketing have replaced conventional digital advertising for pot brands.
- He writes, "Whether it be a pop-up event at a music festival, a conference where companies and investors gather or simply a clean, attractive display at a storefront in a local neighborhood, cannabis and hemp brands should look to quietly infiltrate day-to-day life in an organic way."
- Nordgren is CEO of Arcadian Fund, which invests in ancillary companies.
- The combination of materials in vape cartridges make them "almost impossible" to recycle.
- Armentano: "No state has ever repealed a marijuana legalization law, and two-thirds of adults—including majorities of self-identified Democrats, Republicans and independents."
- Though Berenson claimed failures to legalize in New York, New Jersey and other liberal states show "The pushback against marijuana has only begun."
- Berenson also suggests the possibility of a "narrow compromise" around REC legalization involving restrictions on advertising, a legal age of 23 to 25 and potentially potency limits.
A post at the libertarian Cato Institute suggests a "two-pronged strategy" for federal REC legalization.
A new survey of older Coloradans gauged their attitudes to legalization and consumption habits.
- The survey found seniors, the fastest growing group of cannabis users, are "blurring the lines between MED and REC."
- Lead researcher Brian Kaskie, a professor of health policy at the University of Iowa, said: When we started this research many of my colleagues suggested that this was just about retired baby boomers entering old age who have come back to cannabis as a way of returning to their youth... “But we learned older adults who are using cannabis...are experiencing symptoms and conditions that seem amenable to cannabis."
A piece in the liberal American Prospect suggests governments are thinking about equity all wrong.
- "The government deciding to give consumers’ money to a few thousand lucky license winners, even if it is a relatively diverse group, is a poor attempt at equity," Jon Walker writes.
- [Editorial: As it looks right now, 'a few thousand' is wildly optimistic.]
- Instead he proposes a government run system, similar to what exists in some parts of Canada, which will reinvest in communities most damaged by the war on drugs.
- As far as I'm aware, no state has seriously considered anything like this.
Stat News meets Christian Angermayer a wellGerman businessman betting big on medical uses for psychedelics.
Separately, Axios talks to Catherine Dockery, an investor and former Walmart exec, who is starting a vice investment fund.
- Areas of interest include cannabis, alcohol, harm-reduction tobacco products, sextech, gambling and "highly addictive" eSports.
- Since Dockery isn't a doctor, she says psychedelics will have to reach market before she'll consider investing.
- Investors include Silicon Valley heavyweight Marc Andreessen and investor Bradley Tusk.
The N.Y. Times takes a lengthy trip through what people have called cannabis through the centuries.
- Peter Sokolowski, editor at large at Merriam-Webster (the dictionary people) says, "Words we think of today as leftovers from the 1960s are really leftover from the 1930s,” he said. But it is important to look even further back, he added. Terms like cannabis and ganja go back centuries, and have long been used to describe the plant and its medicinal properties."